Brief: Nextcell Q4 Operating Loss At SEK 4.5 Mln
29/10/2021 07:12
Oct 29 (Reuters) - NextCell Pharma AB NXTCL.ST :
* Q4 OPERATING INCOME AMOUNTED TO TSEK 1 381 (842).
* Q4 OPERATING RESULT AMOUNTED TO TSEK -4 475 (-4 877).
Source text for Eikon: ID:nWkrb19gDz
Further company coverage: NXTCL.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on NextCell Pharma AB
See all newsBrief: NextCell Pharma Q1 Operating Income At SEK 2.8 Million
Brief: Nextcell Pharma Q4 Operating Income SEK 1.8 Mln
Brief: Nextcell Pharma Says ProTrans Data Show Insulin Production Preservation
Brief: NextCell Board Proposes Directed Issue Of 15,000,000 Shares
Brief: Nextcell Decides To Propose Directed Share Issue Of SEK 15 Mln